ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
SABCS 2023 Insights: "OLAnzaPiNE Trial - Evaluating Low-Dose Compared to Standard-Dose Olanzapine With Triple Antiemetic Therapy for Solid Tumors"
By
ecancer
FEATURING
Jyoti Bajpai
By
ecancer
FEATURING
Jyoti Bajpai
Login to view comments.
Click here to Login
